Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial is a research paper published in JCI Insight (2024). On theSindex it has a DataRank of 0.427. It has been cited 12 times, with 4 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.385
From this paper's citation signal
Citation Network Contribution
0.0422
From 2 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 4 citers.
Defense Health Agency
Grant: W911QY2090012
Bloomberg Philanthropies
Grant: 1
State of Maryland
Grant: 2
NIAID
Grant: 3R01AI152078-01S1
Conjugate vaccines for prevention and treatment of cryptococcosis - COVID-19 Revision Supplement
NCATS
Grant: U24TR001609-S3
NHLBI
Grant: 1K23HL151826NIH
Mental Wellness Foundation
Grant: 3
Moriah Fund
Grant: 4
Octapharma
Grant: 5
Healthnetwork Foundation
Grant: 6
Shear Family Foundation
Grant: 7
NIAID NIH HHS
Grant: R01 AI152078
NIGMS NIH HHS
Grant: T32 GM149382
NCATS NIH HHS
Grant: U24 TR001609
NCATS NIH HHS
Grant: UL1 TR001409
NCATS NIH HHS
Grant: UM1 TR004409
NHLBI NIH HHS
Grant: K23 HL151826
NIAID NIH HHS
Grant: T32 AI102623
NCATS NIH HHS
Grant: UL1 TR002001
National Institutes of Health
Grant: 5U24TR001609-06
Johns Hopkins-Tufts Trial Innovation Center
Fields of Study
MeSH Terms
Keywords